Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants experiencing an adverse event of permanent diplopia (double vision) Reports of diplopia across all measured time points · 5‐ to 8‐year‐old children with amblyopia
1 finding from 1 review
Overall survival (taxane‐containing doublet therapy vs taxane monotherapy) · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in overall survival (taxane‐containing doublet therapy vs taxane… compared with chemotherapy (low certainty).
1 finding from 1 review
Progression‐free survival (PSF) · advanced gastric adenocarcinoma
Chemotherapy showed no clear difference in progression‐free survival (taxane‐containing doublet therapy vs… compared with chemotherapy (low certainty).
1 finding from 1 review
Tumour response rate (taxane‐containing doublet therapy vs taxane monotherapy) · advanced gastric adenocarcinoma
It is very uncertain whether chemotherapy changes tumour response rate (taxane‐containing doublet therapy vs taxane… compared with chemotherapy (very low certainty).
1 finding from 1 review
Intervention not reported
Sleep onset latency Participant reports. Scale from 30 to 540 minutes; fewer minutes equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review
Intervention not reported
Wake time after sleep onset Participant reports. Scale from: 30 to 540 minutes; fewer minutes equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review
Intervention not reported
Total sleep time Participant reports. Scale from: 300 to 840; more minutes equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review
Intervention not reported
Next‐day alertness Participant reports. Scale from: 0 to 10 points; higher scores equalled better outcome; CFB and double‐blind average values included · Patients with insomnia
1 finding from 1 review
Intervention not reported
Serious adverse events (as defined in the primary study) Participant reports. Serious adverse events observed during double‐blind treatment period · Patients with insomnia
1 finding from 1 review
Lack of efficacy withdrawal in randomised double‐blind phase · adults with chronic neuropathic pain
1 finding from 1 review
Adverse event withdrawal in randomised double‐blind phase · adults with chronic neuropathic pain
1 finding from 1 review
Intervention not reported
Lack of efficacy withdrawal in randomised double‐blind phase · Adults with chronic neuropathic pain
1 finding from 1 review
Intervention not reported
Adverse event withdrawal in randomised double‐blind phase · Adults with chronic neuropathic pain
1 finding from 1 review
Numbers completing double‐blind treatment Number of participants · patients with an acute manic or mixed episode
Aripiprazole showed no clear difference in numbers completing double‐blind treatment Number of participants compared with placebo (moderate certainty).
1 finding from 1 review
RR 1.03 [0.95, 1.12]
2216 participants
Moderate
Primary anaesthesia failure · Adult patients undergoing hand, wrist or forearm surgery
Multiple leads to lower primary anaesthesia failure compared with double‐injection technique (high certainty).
1 finding from 1 review
Secondary analgesia failure: Intraoperative sedation required · Adult patients undergoing hand, wrist or forearm surgery
Multiple showed no clear difference in secondary analgesia failure ‐ intraoperative sedation required compared with double‐injection technique (high certainty).
1 finding from 1 review
Secondary analgesia failure : Tourniquet pain · Adult patients undergoing hand, wrist or forearm surgery
Multiple leads to lower secondary analgesia failure ‐ tourniquet pain compared with double‐injection technique (high certainty).
1 finding from 1 review
Complete failure of block1 · Adult patients undergoing hand, wrist or forearm surgery
Multiple showed no clear difference in complete failure of block1 compared with double‐injection technique (low certainty).
1 finding from 1 review
Time to readiness for surgery2 (minutes) · Adult patients undergoing hand, wrist or forearm surgery
1 finding from 1 review